In the past when a Biotech firm posted clinical trial results like TNGN just reported--you'd see a pop in the stock price but TNGN went down.These are very odd economic times for sure. Small cap Biotech stocks live/die on PR news releaases on clinical trials and TNGN did not move north but South. Odd!I'm long TNGN but if succesful clinical trials don't move a stock upward Im not sure what will. Any thoughts on this dichotomy?
yes my guess is that this good clinical news is what made this stock jump so much in early Jan 2012
january was a stockfather pump and dump, just like mnel.
We are up 15% from the 19th, i would concentrate on the long term. I think what is happening is that no one wants to chase this stock, so it will be a slow build from here, no crazy 40% up in a day pump and dumps.
good point! like most longs i'm hoping for better things and was disapointed that stock didnt move much on news of succesful trials